Page 1662 - Hematology_ Basic Principles and Practice ( PDFDrive )
P. 1662

1480   Part VIII  Comprehensive Care of Patients with Hematologic Malignancies


        nausea. Rarely, patients need oral or intravenous ondansetron (8 mg   at bedtime and used with caution in elderly patients and in patients
        taken two or three times daily).                      who have cardiac conduction abnormalities or bladder outlet obstruc-
                                                              tion.  Combination  therapy  with  gabapentin  and  nortriptyline  has
                                                              been shown to be more effective than either drug alone in patients
        Respiratory Depression                                with diabetic neuropathy and PHN. 43
                                                                 Selective  serotonin  and  norepinephrine  reuptake  inhibitors
        Naloxone  (Narcan),  given  intravenously,  reverses  opioid-induced   (SSNRIs; e.g., venlafaxine and duloxetine) have been shown to be
                                                          9
        respiratory depression, although repeated doses are often required.    analgesic for a number of neuropathic pain syndromes. There is less
        Respiratory depression can occur in patients with mild-to-moderate   evidence supporting the use of SSRIs for neuropathic pain.
        pain during the initial use of opioids, although it is rare in patients   Corticosteroids given epidurally, intravenously, or orally are useful
        with severe pain and in those chronically receiving opioids. Caution   as antineoplastics (e.g., in leukemia, lymphoma, and myeloma) and
        should be exercised before administering naloxone to patients who   can  also  provide  nonspecific  relief  for  patients  with  spinal  cord
        are chronically receiving opioids to avoid precipitation of severe pain   compression and plexus infiltrations. Doses of 16–100 mg of dexa-
        and withdrawal. In such cases, it is inadvisable to administer the usual   methasone  are  needed  to  reduce  vasogenic  edema  in  spinal  cord
                                                                        9
        0.4 mg/mL dose. Rather, 0.4 mg of naloxone should be diluted with   compression,   but  lesser  doses  (6–20 mg/day)  can  be  helpful  in
        9 mL of saline and 1–2 mL (0.04–0.08 mg) of this dilute mixture   patients  with  plexus  injuries.  Patients  must  be  monitored  for  the
        given every 2–3 minutes until the patient is rousable and breathing   development of oral or esophageal candidiasis and steroid-induced
        at least 10 times/min. Do not give enough to fully waken the patient   delirium.
                               1
        or withdrawal is likely to ensue.  In a comatose patient, endotracheal
        tube placement is recommended to prevent aspiration from the sali-
                                             1
        vation and bronchial spasm that will be induced.  Naloxone should   Bone Pain
        not be administered to an alert patient.
                                                              Adjuvants for bone pain include NSAIDs, corticosteroids, bisphos-
                                                              phonates, receptor activator of nuclear factor κ-B ligand inhibitors
        Adjuvant Analgesics                                   (e.g., denosumab), and the radiopharmaceuticals strontium chloride
                                                               89
                                                                                         9
                                                              ( Sr) and samarium153-lexidronan.  Multiple studies have demon-
        Adjuvant analgesics are a diverse class of medications, which typically   strated the efficacy of bisphosphonates in reducing skeletal complica-
                                                                                          9
        have indications for conditions other than pain. They have analgesic   tions and pain from bone metastases.  Pamidronate and zoledronate
        properties and are often used when an opioid regimen alone is unable   are  recommended  for  patients  with  multiple  myeloma  and  other
        to provide sufficient analgesia or is associated with dose-limiting side   hematologic  malignancies  with  painful  bone  lesions.  Calcium  and
        effects.                                              sometimes  vitamin  D  supplementation  (especially  for  denosumab)
                                                                           44
                                                              are  often  needed.   Also,  the  long-term  use  of  bisphosphonates  is
                                                              associated with a small but meaningful risk of osteonecrosis of the
        Neuropathic Pain                                      jaw.   The  limitations  of  radiopharmaceuticals  include  cost  and
                                                                 44
                                                                      9
                                                              cytopenias.  Given the limited evidence available, a recent Cochrane
        Adjuvant agents for patients with neuropathic pain include anticon-  review did not support the use of calcitonin for control of pain from
        vulsants,  antidepressants,  α 2 -adrenergic  agonists,  corticosteroids,   bone metastases.
        topical agents, γ-aminobutyric acid (GABA) agonists, and NMDA
        RAs. 1,7,9,41  However, the analgesic antidepressants and anticonvulsants
        are  typically  preferred  for  treating  neuropathic  pain  secondary  to   Cannabinoids
        cancer. 42
           The  anticonvulsants  gabapentin  (Neurontin)  and  pregabalin   Long used empirically for their analgesic and antiemetic properties
        (Lyrica) have the fewest side effects and are very effective for patients   in a wide range of illnesses, cannabis and cannabinoid therapies have
        with  neuropathic  pain  from  tumor,  peripheral  neuropathy  from   been subjected to an increasingly large number of controlled clinical
                               41
                                                                                                            45
        tumor or treatment, and PHN.  Despite their names, they have no   trials (of varying size and quality) over the last several decades.  Oral
        effect on GABA receptors, but rather bind to the α-2-delta subunit   cannabis, used for breakthrough pain, was studied in a recent multi-
        of the N-type calcium channels in neurons within the dorsal horn,   center randomized controlled trial, involving 360 patients, who were
        thus inhibiting calcium influx and diminishing neuronal hyperactiv-  started on a long-acting opioid. The study showed analgesic efficacy
                                                                                                               46
        ity. To minimize sedation, doses should be low at first (e.g., gabapentin   in the low and medium dose ranges, which were also well tolerated.
        100 mg three times daily or 300 mg at bedtime; pregabalin 50 mg   Inhaled cannabis, used for nausea and vomiting secondary to active
        twice a day) and should be increased as tolerated every 3–5 days until   cancer  chemotherapy,  was  studied  in  three  randomized  controlled
        analgesia is achieved. The effective dose of gabapentin varies between   trials,  involving  43  subjects  in  total,  which  demonstrated  inhaled
        900  and  3600 mg/day  in  divided  doses  and  that  of  pregabalin  is   cannabis  to  be  an  efficacious  antiemetic.  Additional  studies  have
        150–300 mg twice a day. The pharmacokinetics of gabapentin are   provided evidence for its effect on spasticity, appetite stimulation, and
        unique in that it has a ceiling effect related to a saturable transport   insomnia.
        mechanism in the gut, such that the effects of this drug may plateau
                         42
        during dose escalation.  The most common dose-limiting side effect
        is sedation. Gabapentin and pregabalin need to be renally dosed in   SPECIFIC CLINICAL PROBLEMS
        patients with decreased creatinine clearance. Peripheral edema related
        to  gabapentin  or  pregabalin  may  require  diuretics.  Pregabalin’s   Oral Complications
        gastrointestinal absorption is proportional to the dose throughout the
        effective dose range, making titration simpler. Other, generally less   Oral  complications  of  chemotherapeutic  and  bone  marrow  trans-
        effective  anticonvulsants  used  for  neuropathic  adjuvants  include   plant regimens can be frequent causes of pain. A thorough dental
        phenytoin, carbamazepine, lamotrigine, topiramate, and tiagabine.  evaluation  and  prompt  treatment  of  infections  can  minimize  the
           The tricyclic antidepressants (TCAs; e.g., amitriptyline, nortrip-  discomfort  arising  from  underlying  periodontal  disease  and  caries;
                                                                                                               47
                                            9
        tyline) are effective agents for neuropathic pain.  The TCAs, when   secondary  bacterial,  viral,  and  fungal  infections;  and  mucositis.
        used as adjuvant analgesics, are effective faster and at lower doses than   Preventive regimens include saline, sodium bicarbonate, chlorhexi-
        when they are used as antidepressants (e.g., amitriptyline is effective   dine  gluconate  rinses,  acyclovir,  antifungals,  and  ice.  Palifermin
        within  2–3  days  at  50–100 mg/day).  However,  because  of  their   (recombinant human keratinocyte growth factor [KGF-1]) is used for
        anticholinergic side effects they should be started at doses of 10–25 mg   the prevention and treatment of mucositis induced by conditioning
   1657   1658   1659   1660   1661   1662   1663   1664   1665   1666   1667